Druker BJ - Search Results

1

An activating KRAS mutation in imatinib-resistant chronic myeloid leukemia.

Agarwal A, Eide CA, Harlow A, Corbin AS, Mauro MJ, Druker BJ, Corless CL, Heinrich MC, Deininger MW. Agarwal A, et al. Among authors: druker bj. Leukemia. 2008 Dec;22(12):2269-72. doi: 10.1038/leu.2008.124. Epub 2008 May 29. Leukemia. 2008. PMID: 18509354 No abstract available.

2

A single nucleotide polymorphism in the coding region of ABL and its effects on sensitivity to imatinib.

Crossman LC, O'Hare T, Lange T, Willis SG, Stoffregen EP, Corbin AS, O'Brien SG, Heinrich MC, Druker BJ, Middleton PG, Deininger MW. Crossman LC, et al. Among authors: druker bj. Leukemia. 2005 Nov;19(11):1859-62. doi: 10.1038/sj.leu.2403935. Leukemia. 2005. PMID: 16151465

3

Zoledronate inhibits proliferation and induces apoptosis of imatinib-resistant chronic myeloid leukaemia cells.

Chuah C, Barnes DJ, Kwok M, Corbin A, Deininger MW, Druker BJ, Melo JV. Chuah C, et al. Among authors: druker bj. Leukemia. 2005 Nov;19(11):1896-904. doi: 10.1038/sj.leu.2403949. Leukemia. 2005. PMID: 16167056

4

Mutations of the BCR-ABL-kinase domain occur in a minority of patients with stable complete cytogenetic response to imatinib.

Sherbenou DW, Wong MJ, Humayun A, McGreevey LS, Harrell P, Yang R, Mauro M, Heinrich MC, Press RD, Druker BJ, Deininger MW. Sherbenou DW, et al. Among authors: druker bj. Leukemia. 2007 Mar;21(3):489-93. doi: 10.1038/sj.leu.2404554. Epub 2007 Jan 25. Leukemia. 2007. PMID: 17252009

5

Clonal chromosomal abnormalities in CD34+/CD38- hematopoietic cells from cytogenetically normal chronic myeloid leukemia patients with a complete cytogenetic response to tyrosine kinase inhibitors.

Bumm T, Deininger J, Newell AH, Lawce H, Olson S, Mauro M, Druker B, Deininger M. Bumm T, et al. Leukemia. 2010 Aug;24(8):1525-1528. doi: 10.1038/leu.2010.123. Epub 2010 Jun 10. Leukemia. 2010. PMID: 20535153 Free PMC article. No abstract available.

6

Chronic myelogenous leukemia.

Mauro MJ, Druker BJ. Mauro MJ, et al. Among authors: druker bj. Curr Opin Oncol. 2001 Jan;13(1):3-7. doi: 10.1097/00001622-200101000-00002. Curr Opin Oncol. 2001. PMID: 11148678 Review.

7

Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy.

Hochhaus A, Kreil S, Corbin AS, La Rosée P, Müller MC, Lahaye T, Hanfstein B, Schoch C, Cross NC, Berger U, Gschaidmeier H, Druker BJ, Hehlmann R. Hochhaus A, et al. Among authors: druker bj. Leukemia. 2002 Nov;16(11):2190-6. doi: 10.1038/sj.leu.2402741. Leukemia. 2002. PMID: 12399961 Clinical Trial.

8

Demonstration of Philadelphia chromosome negative abnormal clones in patients with chronic myelogenous leukemia during major cytogenetic responses induced by imatinib mesylate.

O'Dwyer ME, Gatter KM, Loriaux M, Druker BJ, Olson SB, Magenis RE, Lawce H, Mauro MJ, Maziarz RT, Braziel RM. O'Dwyer ME, et al. Among authors: druker bj. Leukemia. 2003 Mar;17(3):481-7. doi: 10.1038/sj.leu.2402848. Leukemia. 2003. PMID: 12646934

9

Detection of ABL kinase domain mutations with denaturing high-performance liquid chromatography.

Deininger MW, McGreevey L, Willis S, Bainbridge TM, Druker BJ, Heinrich MC. Deininger MW, et al. Among authors: druker bj. Leukemia. 2004 Apr;18(4):864-71. doi: 10.1038/sj.leu.2403307. Leukemia. 2004. PMID: 14973502

10

Characterization of BCR-ABL deletion mutants from patients with chronic myeloid leukemia.

Sherbenou DW, Hantschel O, Turaga L, Kaupe I, Willis S, Bumm T, Press RD, Superti-Furga G, Druker BJ, Deininger MW. Sherbenou DW, et al. Among authors: druker bj. Leukemia. 2008 Jun;22(6):1184-90. doi: 10.1038/leu.2008.65. Epub 2008 Mar 20. Leukemia. 2008. PMID: 18354488

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

441 results

Search Page

Filters